peaking to CNBC-TV18 Kaustubh Chaubal, Vice President of the Corporate Finance Group at Moody's Investors Service said that he expects Indian generic companies to grow inorganically in the next 18-24 months. The Indian pharma companies will look at the US, Russia for inorganic growth opportunities.
first published: Dec 12, 2016 01:01 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

